UArizona Issues Alert Over Synthetic Opioid Cyclorphine
University of Arizona Issues Urgent Public Health Warning Over Novel Synthetic Opioid Cyclorphine
The University of Arizona, in coordination with the University of Arizona Police Department (UAPD) and local public health authorities, has issued an urgent drug advisory regarding the emergence of cyclorphine, an ultra-potent novel synthetic opioid (NSO). Recent law enforcement seizures and forensic laboratory analyses across Pima County confirm that cyclorphine contaminates the illicit drug supply, frequently pressed into counterfeit prescription medications marketed to college students.
Cyclorphine presents a severe risk of fatal overdose. Because this novel substance possesses chemical potency levels exceeding standard illicit opioids, students, campus personnel, and the greater Tucson community must understand the risks, recognize overdose symptoms, and know immediate intervention protocols.
I. Overview of the University of Arizona Drug Advisory
+-------------------------------------------------------------------------+
| CAMPUS HEALTH & SAFETY ALERT |
| SUBSTANCE: Cyclorphine (Novel Synthetic Opioid / Benzimidazole Class) |
| RISK LEVEL: Critical / High Overdose Potential |
| COMMON FORMS: Counterfeit "M30" oxycodone, fake Xanax, fake Adderall |
| DETECTION: Standard fentanyl test strips DO NOT reliably detect it |
| ACTION: Carry Naloxone (Narcan), call 911 immediately under ARS 13-3423 |
+-------------------------------------------------------------------------+
A. Details of the Campus Health and UAPD Alert
Campus Health Services and the UAPD distributed the advisory following intelligence from regional narcotics task forces and toxicological screenings of local street seizures. Forensic testing verified cyclorphine in counterfeit pills recovered in metropolitan Tucson and areas adjacent to the university campus.
Key alert details include:
- Illicit Appearance: The drug is not distributed under its chemical name. It is pressed into illicit tablets disguised as legitimate pharmaceuticals, most commonly light blue round tablets marked with “M” and “30” (counterfeit oxycodone).
- Target Audience Risk: College students purchasing what they believe to be prescription stimulants (such as Adderall) or sedatives (such as Xanax) through unregulated online vendors, social media channels, or street dealers face direct exposure.
- Law Enforcement Findings: Multi-agency task forces report that local distribution networks mix novel synthetics into existing illicit batches to increase profit margins and overcome supply chain disruptions affecting standard precursor chemicals.
B. The Context of Novel Synthetic Opioids (NSOs) in Arizona
Arizona has historically operated as a primary transshipment corridor for illicit narcotics. As federal and international interdiction efforts have increased scrutiny on precursor chemicals used to synthesize fentanyl, clandestine laboratories have pivoted toward novel synthetic opioids (NSOs), including benzimidazole-derived opioids (nitazenes) and novel morphinan or piperidine derivatives like cyclorphine.
Counterfeit pill distribution patterns in student settings show high rates of polysubstance contamination:
- Counterfeit Oxycodone (“Blues” / “M30s”): Over 90% of seized illicit M30 pills contain non-pharmaceutical synthetic compounds rather than oxycodone.
- Counterfeit Benzodiazepines (Alprazolam / Xanax): Pressed bars often contain synthetic depressants combined with trace microgram quantities of high-potency opioids.
- Counterfeit Prescription Stimulants (Amphetamine / Adderall): Illicit tableting presses contaminated with opioid residue lead to cross-contamination, causing opioid-naive stimulant users to experience rapid respiratory depression.
II. What Is Cyclorphine?
+-------------------------------------------------------------------------+
| CYCLORPHINE: AT A GLANCE |
| • Classification: Non-fentanyl Novel Synthetic Opioid (NSO) |
| • Mechanism: High-affinity full agonist at mu-opioid receptors |
| • Relative Potency: Multiple times stronger than fentanyl |
| • Dangerous Characteristic: Microgram-level lethal window |
| • Clinical Use: Zero approved veterinary or human medical applications |
+-------------------------------------------------------------------------+
A. Chemical Profile and Pharmacology
Cyclorphine is an unregulated, synthetic opioid exhibiting structural properties that facilitate high-affinity binding to central nervous system receptors. Unlike standard clinical analgesics derived directly from the opium poppy (such as morphine or codeine), cyclorphine is produced entirely via chemical synthesis in non-regulated laboratories.
- Mechanism of Action: Cyclorphine acts as a potent full agonist at the $\mu$-opioid (mu-opioid) receptors located in the brainstem and throughout the central nervous system. Activation of these receptors inhibits the transmission of pain signals, induces severe sedation, and directly suppresses autonomic respiratory drive.
- Lack of Regulated Medical Use: Cyclorphine has never undergone clinical trials for human safety or therapeutic efficacy. It possesses no accepted medical use in the United States and has no standardized manufacturing controls, making dose consistency nonexistent across individual pills or powder batches.
B. Potency Comparison: Cyclorphine vs. Fentanyl and Morphine
Preliminary pharmacological and binding-affinity data place cyclorphine among the most potent synthetic opioid compounds identified in the illicit market.
Potency Spectrum (Approximate Analgesic / Receptor Affinity):
Morphine (1x Baseline)
└── Oxycodone (1.5x)
└── Fentanyl (~50x - 100x)
└── Cyclorphine (Significantly higher than Fentanyl)
- Receptor Affinity: Cyclorphine binds to $\mu$-opioid receptors with extreme tenacity, displacing endogenous ligands rapidly.
- Microgram Lethality: While a lethal dose of morphine is measured in hundreds of milligrams and fentanyl in approximately 2 milligrams, cyclorphine toxicity occurs at sub-milligram and microgram thresholds.
- Rapid Onset: Due to its lipophilic properties, cyclorphine crosses the blood-brain barrier rapidly, inducing near-instantaneous respiratory arrest before an individual can recognize symptoms or self-administer an opioid antagonist.
III. Symptoms and Severe Health Risks
SIGNS OF A CYCLORPHINE OVERDOSE
[ EYES ] [ RESPIRATION ] [ CIRCULATION ]
Pinpoint Pupils Slow / Shallow / Stopped Blue/Gray Lips & Nails
\ | /
\ | /
+---------------------------------------+
| UNRESPONSIVENESS / COMA |
| Victim cannot be woken by voice/pain |
+---------------------------------------+
A. Recognizing Immediate Physical Symptoms
An overdose involving cyclorphine follows the classic opioid toxidrome but manifests faster and with greater severity.
- Respiratory Arrest: Breathing drops below 8–10 breaths per minute, becomes irregular or agonal (gasping/snoring “death rattle”), or ceases entirely.
- Miosis (Pinpoint Pupils): Pupils constrict to microscopic pinpoints, failing to react to light changes.
- Loss of Consciousness: Complete unresponsiveness to verbal commands or physical stimuli (such as a sternal rub).
- Cyanosis: Insufficient oxygenation leads to blue, purple, or ashen-gray discoloration around the lips, tongue, and nail beds.
- Muscle Flaccidity: Limbs become completely limp; the jaw drops open, increasing upper airway obstruction.
- Cardiovascular Collapse: Bradycardia (dangerously low heart rate) and profound hypotension (low blood pressure) leading to pulseless electrical activity (PEA) or cardiac arrest.
B. Secondary and Long-Term Hazards
Surviving a cyclorphine exposure without immediate, aggressive medical intervention carries severe secondary physiological risks:
- Hypoxic-Ischemic Brain Injury: Brain tissue deprived of oxygen for more than 3 to 5 minutes suffers permanent cellular death. Survivors of severe synthetic opioid overdoses may experience cognitive deficits, memory loss, motor dysfunction, or persistent vegetative states.
- Aspiration Pneumonitis: Loss of consciousness impairs protective airway reflexes, causing stomach contents to enter the lungs and resulting in chemical pneumonitis or severe respiratory failure.
- Polysubstance Compounding: Illicit cyclorphine taken alongside alcohol, benzodiazepines, or prescription sedatives produces synergistic central nervous system depression, dramatically reducing the survival window. When taken alongside stimulants, the stimulant masks early sedative cues until sudden respiratory collapse occurs.
IV. Emergency Response and Harm Reduction Protocols
+-------------------------------------------------------------------------+
| EMERGENCY ACTION STEPS FOR OVERDOSE |
| 1. CALL 911 IMMEDIATELY. State exact location and breathing status. |
| 2. ADMINISTER NALOXONE (NARCAN). 1 spray into one nostril. |
| 3. PROVIDE RESCUE BREATHING. 1 breath every 5 seconds if not breathing. |
| 4. REPEAT NALOXONE IF NEEDED. Give 2nd dose after 2-3 min if no change. |
| 5. PLACE IN RECOVERY POSITION once breathing resumes. Stay until EMS. |
+-------------------------------------------------------------------------+
A. Naloxone (Narcan) Response for Cyclorphine Overdoses
Naloxone is an opioid receptor antagonist that displaces opioid molecules from $\mu$-receptors, restoring spontaneous respiration.
- Efficacy: Naloxone remains pharmacologically effective against cyclorphine.
- Requirement for High/Multiple Doses: Because cyclorphine possesses an exceptionally high receptor-binding affinity, standard single doses (4 mg nasal spray) may be insufficient to displace the drug. Responders must be prepared to administer multiple consecutive doses every 2 to 3 minutes until regular spontaneous breathing resumes.
- Airway and Ventilation: If the individual is not breathing, administer rescue breaths using a barrier mask (1 breath every 5 seconds) alongside naloxone administration. Brain death occurs from lack of oxygen; rescue breathing maintains systemic perfusion while the antagonist takes effect.
B. Limitations of Standard Drug Testing Strips
Standard harm reduction testing tools do not provide comprehensive protection against novel synthetic classes:
+-------------------------------------------------------------------------+
| WARNING: FENTANYL TEST STRIPS (FTS) DO NOT DETECT CYCLORPHINE |
| Standard immunoassay strips target specific fentanyl analogs. Non- |
| fentanyl NSOs, such as cyclorphine or nitazenes, yield a FALSE NEGATIVE |
| on standard strips. A negative test strip does NOT mean the pill is safe.|
+-------------------------------------------------------------------------+
Students should never assume a street pill is unadulterated based solely on a negative fentanyl test strip result. The emergence of cyclorphine bypasses common commercial point-of-care test kits.
C. Legal Protections: Arizona’s Good Samaritan Law
Fear of legal consequences must never delay emergency medical intervention. Under Arizona Revised Statutes (A.R.S.) § 13-3423, individuals are protected from prosecution when seeking emergency aid:
- Immunity Scope: A person who experiences or witnesses a drug-related overdose and seeks emergency medical assistance in good faith will not be charged or prosecuted for possession or use of a controlled substance or drug paraphernalia.
- Conditions: The caller must remain on the scene with the individual experiencing the overdose, provide necessary location details to dispatchers, and cooperate fully with emergency medical technicians and law enforcement officers.
ARIZONA GOOD SAMARITAN LAW (A.R.S. § 13-3423)
+-------------------------------------------------------------+
| STEP 1: Witness overdose / medical emergency |
| STEP 2: Call 911 immediately |
| STEP 3: Stay with victim & cooperate with first responders |
| RESULT: Legal protection from minor drug possession charges|
+-------------------------------------------------------------+
V. University of Arizona and Local Tucson Resources
A. Campus-Specific Support and Prevention
The University of Arizona maintains multiple on-campus health, safety, and addiction prevention facilities:
- Campus Health Services (CHS):
- Location: Highland Commons, 1224 E. Lowell St.
- Services: Primary medical care, harm reduction education, free naloxone distribution, confidential substance misuse consultations.
- Web / Phone:
health.arizona.edu| (520) 621-6490
- Counseling and Psych Services (CAPS):
- Location: Third floor of Highland Commons (with satellite offices across campus).
- Services: Individual psychological counseling, substance use disorder treatment programs, and crisis stabilization.
- Crisis Line: (520) 621-3334 (Available 24/7)
- Free Narcan Distribution Points:
- Pick up free naloxone nasal spray kits at the Campus Health Pharmacy, designated residence hall front desks, and the Associated Students of the University of Arizona (ASUA) student government offices.
- University of Arizona Police Department (UAPD):
- Emergency Contact: Dial 911
- Non-Emergency Dispatch: (520) 621-8273
- Location: 1852 E. First St.
B. Community and Pima County Public Health Resources
Students living off-campus or community members can access wider regional services throughout Tucson:
- Pima County Health Department Harm Reduction Division:
- Free harm reduction kits, community naloxone training, sterile supplies, and educational resources.
- Location: 3950 S. Country Club Rd., Tucson, AZ.
- Contact: (520) 724-7770
- 988 Suicide & Crisis Lifeline:
- Dial or text
988(nationwide 24/7 toll-free mental health and substance crisis access).
- Dial or text
- Southern Arizona AIDS Foundation (SAAF) Harm Reduction Clinic:
- Comprehensive community testing, outreach, and harm reduction support.
- Contact: (520) 628-7223
VI. Frequently Asked Questions (FAQ)
What is cyclorphine, and why is it dangerous?
Cyclorphine is an ultra-potent novel synthetic opioid (NSO) belonging to a class of non-fentanyl synthetic compounds. It is dangerous because of its high binding affinity to central nervous system $\mu$-opioid receptors, its rapid onset of fatal respiratory depression, and its presence in counterfeit prescription pills sold illicitly on campus and across Tucson.
Is cyclorphine stronger than fentanyl?
Yes. Pharmacological receptor-binding analyses indicate that cyclorphine possesses significantly higher potency than standard pharmaceutical or illicit fentanyl. Doses measured in micrograms can trigger full respiratory arrest, particularly in individuals with no baseline opioid tolerance.
Does Narcan reverse a cyclorphine overdose?
Yes, naloxone (Narcan) functions as an effective opioid antagonist against cyclorphine. However, because cyclorphine binds so tightly to opioid receptors, reversing an overdose often requires multiple doses of naloxone. Responders should administer one dose, initiate rescue breathing, and administer additional doses every 2 to 3 minutes if normal breathing does not resume.
Can test strips detect cyclorphine in street drugs?
No. Standard commercially available fentanyl test strips (FTS) are engineered specifically to detect fentanyl and its close structural analogs. They do not cross-react with non-fentanyl synthetic opioids like cyclorphine. A negative result on a fentanyl strip provides zero guarantee that the drug is free from cyclorphine.
Where can University of Arizona students get free Narcan on campus?
Students can obtain free naloxone nasal spray kits at:
- Campus Health Pharmacy (Highland Commons).
- Designated Residence Hall Front Desks across campus.
- The ASUA Student Government Office (Student Union Memorial Center).
- Pima County Health Department Outreach Clinics.
